Michael P. Dube - Jul 1, 2024 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
VP, PAO and Interim PFO
Signature
/s/ James Basta, attorney-in-fact
Stock symbol
NTLA
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 01:15 PM
Previous filing
Apr 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Award $0 +17.8K +57.01% $0.00 49K Jul 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.